Heiss BL, Chang E, Gao X, Truong T, et al. US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer. J Clin Oncol 2024 Mar 7:JCO2302182. doi: 10.1200/JCO.23.02182.
PMID: 38452327